PHAR
Nexus Energy Services, Inc.
NASDAQ · Healthcare · Biotechnology · NL
$10.55
−2.13%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- $0.10
- Revenue estimate
- $102.9M
Latest reported
- Last report date
- Jul 30, 2026
- EPS actual
- $0.02
- EPS estimate
- $0.06
- Revenue actual
- $90.2M
- Revenue estimate
- $100.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +39.6%
- Revenue beats (12Q)
- 7
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $38
- PT range
- $37 – $38
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 30, 2026 | $0.06 | $0.02 | Miss -68.25% | $90.2M |
| May 7, 2026 | $0.05 | -$0.07 | Miss -240.00% | $72.4M |
| Mar 13, 2026 | $0.01 | $0.07 | Beat 366.67% | $90.6M |
| Nov 6, 2025 | $0.05 | $0.10 | Beat 100.00% | $97.3M |
| Jul 31, 2025 | -$0.10 | $0.06 | Beat 160.00% | $110.6M |
| May 8, 2025 | -$0.25 | -$0.22 | Beat 12.00% | $86.7M |
| Mar 13, 2025 | $0.07 | $0.05 | Miss -28.57% | $96.0M |
| Oct 24, 2024 | $0.01 | -$0.02 | Miss -300.00% | $83.8M |
| Aug 1, 2024 | -$0.00 | -$0.01 | Miss -400.00% | $79.6M |
| Mar 14, 2024 | $0.05 | -$0.03 | Miss -160.00% | $59.7M |
| Oct 26, 2023 | $0.13 | $0.05 | Miss -61.54% | $70.3M |
| Aug 3, 2023 | -$0.02 | $0.02 | Beat 200.00% | $59.9M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026